Shie CB - Search Results

1

Independent Risk Factors Predicting Eradication Failure of Hybrid Therapy for the First-Line Treatment of Helicobacter pylori Infection.

Chen CL, Wu IT, Wu DC, Lei WY, Tsay FW, Chuah SK, Chen KY, Yang JC, Liu YH, Kuo CH, Shiu SI, Shie CB, Lin KH, Lee CL, Hsu PI. Chen CL, et al. Among authors: shie cb. Microorganisms. 2023 Dec 19;12(1):6. doi: 10.3390/microorganisms12010006. Microorganisms. 2023. PMID: 38276175 Free PMC article.

2

Equivalent efficacies of reverse hybrid and concomitant therapies in first-line treatment of Helicobacter pylori infection.

Hsu PI, Tsay FW, Kao JY, Peng NJ, Tsai KW, Tsai TJ, Kuo CH, Kao SS, Wang HM, Chen YH, Shie CB, Wu DC; Taiwan Acid-related Disease & Microbiota (TARD-M) Consortium. Hsu PI, et al. Among authors: shie cb. J Gastroenterol Hepatol. 2020 Oct;35(10):1731-1737. doi: 10.1111/jgh.15034. Epub 2020 Mar 31. J Gastroenterol Hepatol. 2020. PMID: 32167605 Free article. Clinical Trial.

3

Tetracycline-levofloxacin versus amoxicillin-levofloxacin quadruple therapies in the second-line treatment of Helicobacter pylori infection.

Hsu PI, Tsay FW, Kao JY, Peng NJ, Chen YH, Tang SY, Kuo CH, Kao SS, Wang HM, Wu IT, Shie CB, Chuah SK, Wu DC; Taiwan Acid-related Disease, Microbiota (TARD-M) Consortium. Hsu PI, et al. Among authors: shie cb. Helicobacter. 2021 Oct;26(5):e12840. doi: 10.1111/hel.12840. Epub 2021 Aug 12. Helicobacter. 2021. PMID: 34390083 Clinical Trial.

4

The efficacy of culture-guided versus empirical therapy with high-dose proton pump inhibitor as third-line treatment of Helicobacter pylori infection: A real-world clinical experience.

Wang JW, Hsu PI, Lin MH, Kao J, Tsay FW, Wu IT, Shie CB, Wu DC. Wang JW, et al. Among authors: shie cb. J Gastroenterol Hepatol. 2022 Oct;37(10):1928-1934. doi: 10.1111/jgh.15942. Epub 2022 Jul 20. J Gastroenterol Hepatol. 2022. PMID: 35816187

5

REAP-HP survey 2020: Comparing the real-world practice and expectation in Helicobacter pylori eradication of the Taiwanese gastroenterologists in 2015 and 2020.

Chuah YY, Wu DC, Chuah SK, Chen KY, Yang JC, Lee CL, Chen CL, Shiu SI, Shie CB, Shih CA, Tsay FW, Liu YH, Hsu PI; Taiwan Acid-related Disease & Microbiota Consortium (TARD-M). Chuah YY, et al. Among authors: shie cb. Helicobacter. 2022 Dec;27(6):e12931. doi: 10.1111/hel.12931. Epub 2022 Sep 25. Helicobacter. 2022. PMID: 36161426

6

Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial.

Hsu PI, Chen KY, Tai WC, Yang JC, Tsay FW, Liu YH, Chen CL, Lee CL, Yeh HZ, Kuo CH, Chuah SK, Lee HC, Shie CB, Shiu SI, Kao JY, Yamaoka Y, Graham DY, Wu DC; Taiwan Acid-related Disease (TARD) Study Group. Hsu PI, et al. Among authors: shie cb. Am J Gastroenterol. 2023 Jul 1;118(7):1184-1195. doi: 10.14309/ajg.0000000000002255. Epub 2023 Mar 20. Am J Gastroenterol. 2023. PMID: 36940437 Clinical Trial.

7

Update on the second-line treatment of Helicobacter pylori infection: a narrative review.

Shih CA, Shie CB, Tai WC, Chuah SK, Lee HC, Hsu PI. Shih CA, et al. Among authors: shie cb. Therap Adv Gastroenterol. 2023 Sep 4;16:17562848231192750. doi: 10.1177/17562848231192750. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37675247 Free PMC article. Review.

8

Omeprazole vs famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: A randomized controlled trial.

Tseng ZF, Hsu PI, Peng NJ, Kao SS, Tsay FW, Cheng JS, Chen WC, Tsai KF, Tang SY, Chuah SK, Shie CB. Tseng ZF, et al. Among authors: shie cb. J Chin Med Assoc. 2021 Jan 1;84(1):19-24. doi: 10.1097/JCMA.0000000000000465. J Chin Med Assoc. 2021. PMID: 33230059 Clinical Trial.

9

Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users.

Hsu JT, Hsu PI, Shie CB, Chuah SK, Wu IT, Huang WW, Tang SY, Tsai KF, Kuo LF, Ghose S, Hsu JC, Shih CA. Hsu JT, et al. Among authors: shie cb. Medicina (Kaunas). 2022 Mar 17;58(3):436. doi: 10.3390/medicina58030436. Medicina (Kaunas). 2022. PMID: 35334612 Free PMC article.

10

Update on the first-line treatment of Helicobacter pylori infection in areas with high and low clarithromycin resistances.

Shih CA, Shie CB, Hsu PI. Shih CA, et al. Among authors: shie cb. Therap Adv Gastroenterol. 2022 Nov 22;15:17562848221138168. doi: 10.1177/17562848221138168. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 36458050 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page